Tissue factor (TF) initiates the extrinsic pathway of blood coagulation by acting as a cofactor for Factor VII. Inhibition of the Factor VIIa-TF complex is mediated by the tissue factor pathway inhibitor (TFPI), which is a serine protease inhibitor with three Kunitz-type domains. The localization of
Tissue factor and tissue factor pathway inhibitor levels in coronary artery disease: Correlation with the severity of atheromatosis
✍ Scribed by Luciana Moreira Lima; Marinez Oliveira Sousa; Luci Maria Sant'Ana Dusse; Marcelo Carvalho Lasmar; Bashir A. Lwaleed; Maria das Graças Carvalho
- Book ID
- 116913667
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 195 KB
- Volume
- 121
- Category
- Article
- ISSN
- 0049-3848
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPI and vascular endothelial cell injury. Plasma TF (273 ± 90 pg/ml) and TFPI (252 ± 125 ng/ml) levels wer
We measured the plasma levels of tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in patients with disseminated intravascular coagulation (DIC) to examine the relationship between TFPl and vascular endothelial cell injury. Plasma TF (273 2 90 pg/ml) and TFPl (252 2 125 nglml) levels wer